Hepatitis C Service Delivery in Prisons: Peer Education From the “Guys in Blue”

Journal of Correctional Health Care

Volumn 11, Issue 4, 2005, Pages 347-368

  Munoz Plaza, Corrine E ^a   Strauss, Shiela M ^a   Astone, Janetta M ^a   Des Jarlais, Don C ^b   Hagan, Holly ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84998183844     PISSN: 10783458     EISSN: None     Source Type: Journal    
DOI: 10.1177/107834580401100404     Document Type: Article

References (34)

1. Allen, S. A. (2003). Developing a systematic approach to hepatitis C for correctional systems: Controversies and emerging consensus. HEPP Report, 6(4), 1-4. Available at http://www.hivcorrections.org
2. Allen, S. A., Spaulding, A. C., Osei, A. M., Taylor, L. E., Cabral, A. M., & Rich, J. D. (2003). Treatment of chronic hepatitis C in a state correctional facility. Annals of Internal Medicine, 138(3), 187-190.
3. Alter, M. J., Kruszon-Moran, D., Nainan O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988-1994. New England Journal of Medicine, 341(8), 556-562.
4. Alter M. J., & Moyer, L. A. (1998). The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18(Suppl. 1), S6-10.
5. Association of State and Territorial Health Officials. (2000, November). Hepatitis C & incarcerated populations: The next wave for correctional health initiatives. Washington, DC: Author. Retrieved February 18, 2004, from http://www.astho.org/pubs/HepC-Incarcerated.pdf
6. Boudin, K., Carrero, I., Clark, J., Flourney, V., Loftin, K., Martindale, S., et al. (1999). ACE: A peer education and counseling program meets the needs of incarcerated women with HIV/AIDS issues. Journal of the Association of Nurses in AIDS Care, 10(6), 90-98.
7. Centers for Disease Control and Prevention. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report, 47(RR-19), 1-39.
8. Centers for Disease Control and Prevention. (2001, August). Drug use, HIV, and the criminal justice system. Retrieved January 3, 2003, from http://www.thebody.com/cdc/drug-use.html
9. Centers for Disease Control and Prevention. (2002, September). Viral hepatitis and the criminal justice system (Fact Sheet). Available at http://www.cdc.gov/idu/hepatitis/viralhep-crimhaljust.htm
10. Centers for Disease Control and Prevention. (2003a). Prevention and control of infections with hepatitis viruses in correctional settings. Morbidity and Mortality Weekly Report, 52(RR-1), 1-35.
11. Centers for Disease Control and Prevention. (2003b, August). Viral hepatitis C (Fact Sheet). Available at http://www.cdc.gov/ncidodldiseases/hepatitis/c/fact.htm
12. DeGroot, A. S., & Bick, J. (2000). The correctional doctor's dilemma: Hepatitis C treatment. HEPP News, 3(6), 1-6. Available at http://www.hivcorrections.org
13. Durose, M. R., & Langan, P. A. (2003). Felony sentences in state courts, 2000 (Bureau of Justice Statistics Bulletin, NCJ 198821). Washington, DC: U.S. Department of Justice, Office of Justice Programs.
14. Edlin, B. R. (2002). Prevention and treatment of hepatitis C in injection drug users. Hepatology 36 (5), Suppl. 1, S210-S219.
15. Fielding, J. E., & Kelch, D. R. (1998, February). Hepatitis C: A silent, deadly health threat: Data, education, research needed. Health Watch: Focus on Prevention, 1-4. Sacramento, CA: California Center for Health Improvement.
16. Fox, R. K., Currie, S., Wright, T. L., Tobler, L., Dailey, P., Phelps, B., et al. (2002). Prevalence of hepatitis C in a sample of California prison inmates [Abstract]. Journal of General Internal Medicine, 17(Suppl. 1), 111-111.
17. Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18(Suppl. 1), S11-S19.
18. Grinstead, O., Faigeles, B., & Zack, B. (1997). The effectiveness of peer HIV education for male inmates entering state prison. Journal of Health Education, 28 (6), November/December Suppl., S31-S37.
19. Grinstead, O. A., Zack, B., & Faigeles, B. (1999). Collaborative research to prevent HIV among male prison inmates and their female partners. Health Education and Behavior, 26(2), 225-238.
20. Hagan, H., McGough, J. P., Thiede, H., Weiss, N. S., Hopkins, S., & Alexander, E. R. (1999). Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology, 149(3), 203-213.
21. Hagan, H., Thiede, H., Weiss, N. S., Hopkins, S. G., Duchin, J. S., & Alexander, E. R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91(1), 42-46.
22. Half a million Californians in jeopardy: Hearing on hep C reveals California is unprepared for latest public health epidemic. (1999, November 12). PR Newswire. Retrieved January 20, 2004, from http://www.aegis.com/news/pr/1999/PR991107.html
23. Hammett, T. M. (2003). Adopting more systematic approaches to hepatitis C treatment in correctional facilities. Annals of Internal Medicine, 138(3), 235-236.
24. Hammett, T. M., Gaiter, J. L., & Crawford, C. (1998). Reaching seriously at-risk populations: Health interventions in criminal justice settings. Health Education and Behavior, 25(1), 99-120.
25. Hammett, T. M., Harmon, P., & Maruschak, L. M. (1999). 1996- 1997 update: HI V/AIDS, STDs, and TB in correctional facilities (NCJ 176344). Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics.
26. Hammett, T. M., Harmon, M. P., & Rhodes, W. (2002). The burden of infectious disease among inmates of and releases from US correctional facilities, 1997. American Journal of Public Health, 92(11), 1789-1794.
27. Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000). Pathogenisis, natural history, treatment, and prevention of hepatitis C. Annals of Internal Medicine, 132(4), 296-305.
28. Mahon, N. (1996). New York inmates' HIV risk behaviors: The implications for prevention policy and programs. American Journal of Public Health, 86(9), 1211-1215.
29. National Commission on Correctional Health Care. (1999, November). The management of hepatitis C in correctional institutions. Chicago: Author. Retrieved February 19, 2004, from http://www.ncchc.org/resources/statements/hepc.html
30. National Institutes of Health. (2002). Management of hepatitis C: 2002 (Consensus Conference Statement). Bethesda, MD: Author. Available at http://consensus.nih.gov/2002/2002HepatitisC2002116html.htm
31. Rich, J. D., Holmes, L., Salas, C., Macalino, G., Davis, D., Ryczek, J., et al. (2001). Successful linkage of medical care and community services for HIV-positive offenders being released from prison. Journal of Urban Health, 78, 279-289.
32. Ruiz, J. D., Molitor, F., & Plagenhoef, J. A. (2002). Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS, 16(16), 2236-2238.
33. Spaulding, A., Greene, C., Davidson, K., Shneidermann, M., & Rich, J. (1999). Hepatitis C in state correctional facilities. Preventive Medicine, 28(1), 92-100.
34. University of California San Francisco. (2000, August). What is the role of prisons in HIV, hepatitis, STD and TB prevention? (Fact Sheet no. l3ER). San Francisco: UCSF Center for AIDS Prevention Studies. Available at http://www.caps.ucsf.edu/inmaterev.html